Plasma microRNA-155-5p is increased among patients with chronic kidney disease and nocturnal hypertension
MicroRNA play multiple roles in the regulation of blood pressure. Nevertheless, to date no study has assessed the association between microRNA plasma expression and blood pressure (BP) control in chronic kidney disease (CKD) patients. Given this background, we evaluated the plasma expression of miR-155-5p, a translational inhibitor of angiotensin receptor type 1, in CKD patients, to determine the association between miR-155-5p level and BP control.
Source: Journal of the American Society of Hypertension - Category: Cardiology Authors: Dominika Klimczak, Marek Kuch, Tomasz Pilecki, Dorota Zochowska, Agnieszka Wirkowska, Leszek Paczek Tags: Research Article Source Type: research